At the 2023 DealBook Summit, Andrew Sorkin aimed to show the “true Elon Musk,” offering rare insight into the billionaire’s mindset and media perspective.
Pfizer’s $10B bet on Metsera could revive its obesity drug ambitions—or become a costly misstep, as CEO Albert Bourla acknowledges the risk.
CoreWeave posts $1.36B Q3 revenue, expands major AI partnerships, and sees 164% stock growth since IPO despite a narrowed quarterly loss.
At the 2023 DealBook Summit, Andrew Sorkin aimed to show the “true Elon Musk,” offering…
India’s tech workers turn to China’s new K-visa as U.S. H-1B hurdles grow, boosting Beijing’s…
Musk hints Tesla and xAI are “trending toward convergence” after shareholders reject an investment proposal,…
A Delta pilot’s touching promise to his daughter calms nervous flyers, earning millions of views…
Sign in to your account